Angiotensin ii induces migration and Pyk2/paxillin phosphorylation of human monocytes

Hypertension

Volumn 37, Issue 2 II, 2001, Pages 587-593

  Kintscher, Ulrich ^a,b   Wakino, Shu ^a   Kim, Sarah ^a   Fleck, Eckart ^b   Hsueh, Willa A ^a   Law, Ronald E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DEUTSCHES HERZZENTRUM BERLIN   (Germany)

Author keywords

Angiotensin; Atherosclerosis; Monocytes; Phosphorylation

Indexed keywords

ANGIOTENSIN; PAXILLIN;

ATHEROSCLEROSIS; CELL MIGRATION; CELL MOTION; CELL STIMULATION; CONFERENCE PAPER; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; INFLAMMATORY CELL; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VASCULAR SMOOTH MUSCLE;

EID: 0035094445     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.37.2.587     Document Type: Conference Paper

References (47)

1. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients: The Heart Outcomes Prevention Evaluation Study Investigators
2. Anti-atherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit
3. The angiotensin-converting enzyme inhibitor, fosinopril, and the angiotensin II receptor antagonist, losartan, inhibit LDL oxidation and attenuate atherosclerosis independent of lowering blood pressure in apolipoprotein E deficient mice
4. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice
5. Angiotensin II, atherosclerosis, and aortic aneurysms
6. Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells
7. Angiotensin II-induced leukocyte adhesion on human coronay endothelial cells is mediated by E-selectin
8. Atherosclerosis: An inflammatory disease
9. Endothelial-leukocyte adhesion molecules in human disease
10. Leucocyte-endothelial interactions and regulation of leucocyte migration
11. Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice
12. RAFTK/Pyk2 tyrosine kinase mediates the association of p190 RhoGAP with RasGAP and is involved in breast cancer cell invasion
13. Paxillin
14. Targeting of PYK2 to focal adhesions as a cellular mechanism for convergence between integrins and G protein-coupled receptor signaling cascades
15. A calcium-dependent tyrosine kinase splice variant in human monocytes: Activation by a two-stage process involving adherence and a subsequent intracellular signal
16. Lipopolysaccharide induces actin reorganization and tyrosine phosphorylation of Pyk2 and paxillin in monocytes and macrophages
17. Regulation of calcium-sensitive tyrosine kinase Pyk2 by angiotensin II in endothelial cells: Roles of Yes tyrosine kinase and tyrosine phosphatase SHP-2
18. Central role of the MAPK pathway in ang II-mediated DNA synthesis and migration in rat vascular smooth muscle cells
19. PPAR gamma-ligands inhibit migration mediated by multiple chemoattractants in vascular smooth muscle cells
20. pp60(c-src) is required for cell locomotion regulated by the hyaluronanreceptor RHAMM
21. A role for p38(MAPK)/HSP27 pathway in smooth muscle cell migration
22. Characterization of the structure and function of a new mitogen-activated protein kinase (p38beta)
23. Activation and suppression of pp60c-src transforming ability by mutation of its primary sites of tyrosine phosphorylation
24. Angiotensin. LDL peroxidation and atherosclerosis
25. Angiotensin II increases macrophage-mediated modification of low density lipoprotein via a lipoxygenase-dependent pathway
26. Preactivated peripheral blood monocytes in patients with essential hypertension
27. Activation of human peripheral monocytes by angiotensin II
28. Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-l expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis
29. Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease
30. Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: Potential implications for inflammation and plaque instability
31. FAK integrates growth-factor and integrin signals to promote cell migration
32. Phosphorylation of tyrosine residues 31 118 on paxillin regulates cell migration through an association with CRK in NBT-II cells
33. Angiotensin II induces nuclear factor-kappa B activation in cultured neonatal rat cardiomyocytes through protein kinase C signaling pathway
34. Regulation of matrix metalloproteinase expression in tumor invasion
35. Angiotensin II and alpha(v)beta(3) integrin expression in rat neonatal cardiac fibroblasts
36. Angiotensin II signal transduction in vascular smooth muscle: Pathways activated by specific tyrosine kinases
37. Angiotensin II activates pp60c-src in vascular smooth muscle cells
38. Agonist-stimulated cytoskeletal reorganization and signal transduction at focal adhesions in vascular smooth muscle cells require c-Src
39. Involvement of PYK2 in angiotensin II signaling of vascular smooth muscle cells
40. p38 Mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II: Role in vascular smooth muscle cell hypertrophy
41. Role of calcium-sensitive tyrosine kinase Pyk2/CAKbeta/RAFTK in angiotensin II induced Ras/ERK signaling
42. Activation of p38 mitogen-activated protein kinase by PYK2/related adhesion local tyrosine kinase-dependent mechanism
43. Protein kinase C, but not tyrosine kinases or Ras, plays a critical role in angiotensin II-induced activation of Raf-l kinase and extracellular signal-regulated protein kinases in cardiac myocytes
44. Activation of extracellular signal-regulated kinases (ERKI/2) by angiotensin II is dependent on c-Src in vascular smooth muscle cells
45. Factor VIIa/tissue factor-induced signaling via activation of Src-like kinases, phosphatidylinositol 3-kinase, and Rac
46. Src and Cas mediate INK activation but not ERK1/2 and p38 kinases by reactive oxygen species
47. Peroxisome proliferator-activated receptor and retinoid X receptor ligands inhibit monocyte chemotactic protein-l-directed migration of monocytes